Bio Essence (BIOE) Other Accumulated Expenses (2021 - 2024)

Bio Essence (BIOE) recorded quarterly Other Accumulated Expenses of $2306.0 in Q4 2024, down 83.24% quarter-over-quarter from $13759.0 in Q3 2021.

Bio Essence (BIOE) Other Accumulated Expenses (2021 - 2024) Analysis & Trends

Bio Essence's Other Accumulated Expenses history runs 2 years deep, the most recent figure standing at $2306.0 for Q4 2024.

In Q4 2024, Other Accumulated Expenses changed N/A year-over-year to $2306.0; the TTM figure through Dec 2024 stood at $2306.0 (changed N/A YoY), while the FY2024 annual figure was $2306.0, changed N/A from the prior year.
Other Accumulated Expenses was $2306.0 for Q4 2024 at Bio Essence, down from $13759.0 in the prior quarter.
In the past five years, Other Accumulated Expenses ranged from a high of $13759.0 in Q3 2021 to a low of $2306.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn
10	Bio Essence	-	-	319,353.00

Download Data